Metformin could reduce viral affinity for angiotensin-converting enzyme 2 and inhibit inflammation via adenosine monophosphate-activated protein activation, potentially protecting against severe COVID-19 [51, 52]. This evidence concerns the gene ACE2 and COVID-19.